G G Chabot

1.7k citations
24 papers · 1.4k indexed · h-index 15
Topics
Cancer therapeutics and mechanisms (10 papers)Lung Cancer Research Studies (9 papers)Cancer Treatment and Pharmacology (6 papers)

In The Last Decade

G G Chabot

23 papers receiving 1.3k citations

Peers

G G Chabot
Comparison fields: 5 of 84
  • Oncology 1.0k
  • Molecular Biology 915
  • Pulmonary and Respiratory Medicine 169
  • Pharmacology 116
  • Surgery 115
Replace A Wakui with:
A Wakui Japan
M. Mahjoubi France
Satomi Tsukahara Japan
E Gupta United States
Yoji Ikegami Japan
Isabelle Hennebelle France
Yasuyoshi Kawato Japan
R J van Alphen Netherlands
Tina Colombo Italy
Chun-ling Dai China
G G Chabot relative to A Wakui Japan A Wakui's profile →
Citations per field
00.5×
A Wakui · 1×
Citations per year

Countries citing papers authored by G G Chabot

Since Specialization
Citations

This map shows the geographic impact of G G Chabot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G G Chabot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G G Chabot more than expected).

Fields of papers citing papers by G G Chabot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G G Chabot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G G Chabot. The network helps show where G G Chabot may publish in the future.

Co-authorship network of co-authors of G G Chabot

This figure shows the co-authorship network connecting the top 25 collaborators of G G Chabot. A scholar is included among the top collaborators of G G Chabot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G G Chabot. G G Chabot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Pharmacocinétique de l'irinotecan
2
2
[Irinotecan pharmacokinetics].
4
3 23
4 23
5 74
6 249
7 94
8 149
9 97
10 1
11 13
12 8
13 51
14 12
15 36
16 215
17 14
18 12
19 40
20
Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy.
88

About G G Chabot

G G Chabot is a scholar working on Oncology, Pharmacology and Neurology, having authored 24 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), Lung Cancer Research Studies (9 papers) and Cancer Treatment and Pharmacology (6 papers). The work is most often cited by research in Oncology (1.0k citations), Toxicology (65 citations) and Molecular Biology (915 citations). G G Chabot has collaborated with scholars based in France, United States and Germany. Frequent co-authors include D Abigerges, Patrice Herait, Alain Gouyette, Jean‐Pierre Armand, Daniel Gandía, M Forni, R. Bugat, Claudia Côté, M. Mahjoubi and P. Armand. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026